ReviewJAC-antimicrobial resistance2026

When might we consider using the newer β-lactam agents as empirical therapy against presumed carbapenem-resistant gram-negative infections?

Stelios F Assimakopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.